Women's Health Advocate Amy Schumer Joins TMRW Life Sciences as Investor
Summary
"Since the beginning of human IVF over 40 years ago, significant treatment advancements have been made; however, the organization and management of frozen eggs and embryos have remained mostly unchanged. With the introduction of TMRWs unique digital chain of custody and technology platform, physicians and patients are provided unparalleled visibility, protection, and peace of mind, allowing clinicians to focus on what they do best, building families. "Our technology was designed with safety and transparency top of mind, empowering physicians and patients to track, manage and store these precious frozen eggs and embryos at all times. "TMRW Life Sciences has created the only FDA-cleared automated solution that digitally tracks, monitors, and manages frozen eggs and embryos used in IVF. With significant continued growth in fertility services and the projected number of IVF births on the rise, TMRW provides a scalable solution for clinics bringing the care of frozen eggs and embryos into the 21st century.